| Financial Year |
March 31 2023 |
| Monetary Funds |
2,433,139,700.64 |
| Held-for-trading Financial Assets |
204,439,056.83 |
| Notes Receivable |
-- |
| Accounts Receivable |
3,216,196,631.78 |
| Advances to Suppliers |
767,780,067.83 |
| Other Receivables |
69,797,747.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,911,368,658.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
25,469,084.72 |
| Other Current Assets |
259,479,312.69 |
| Total Current Assets |
9,605,615,982.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
121,154,652.82 |
| Long-term Equity Investment |
1,013,910,668.56 |
| Investment Properties |
85,634,033.12 |
| Fixed Assetes |
9,272,702,964.79 |
| Under-construction Projects |
552,110,045.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
267,330,648.77 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,775,045.81 |
| Deferred Income Tax Assets |
163,218,514.45 |
| Other Non-Current Assets |
243,761,415.87 |
| Sub-Total of Non-Current Assets |
12,294,212,306.74 |
| Total Assets |
21,899,828,289.43 |
| Short-Term Loans |
1,791,016,361.96 |
| Trading Financial liabilities |
-- |
| Notes Payable |
417,741,290.26 |
| Accounts Payable |
1,318,764,956.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
80,591,957.87 |
| Taxes Payable |
77,400,837.60 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
113,151,947.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,417,726,048.36 |
| Other Current Liabilities |
23,081,305.50 |
| Sub-Total of Current Liabilities |
5,397,452,203.36 |
| Long-term Loans |
59,990,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,226,473,092.29 |
| Special Payable |
-- |
| Estimatied Liabilities |
40,498,136.01 |
| Deferred Income Tax Liabilities |
4,995,430.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,960,204,989.92 |
| Total Liabilities |
10,357,657,193.28 |
| Paid-In Capital(Or Share Stock) |
2,414,602,861.00 |
| Capital Surplus |
4,944,784,526.72 |
| Surplus Reserve |
190,587,004.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,913,874,844.61 |
| Minority Stockholder's Interest |
73,582,993.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,468,588,102.91 |
| Owner's Equity（Stockholder's Equity） |
11,542,171,096.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,899,828,289.43 |
